Mother
and Baby

with BabySafe

At Synapse Laboratory, we are dedicated to safeguarding maternal and infant health with our BabySafe brand. Offering a full spectrum of advanced testing solutions, we support every stage of care—from prenatal screening to postnatal management.

Our services are meticulously designed to identify and address potential health issues early, ensuring timely interventions that lead to healthier outcomes for both mothers and their babies.

Prenatal Testing

Our prenatal testing services provide expectant parents with vital insights into both the baby’s genetic health and the mother’s well-being. By detecting potential chromosomal abnormalities and maternal health issues early, we enable informed decisions and proactive care, promoting a healthier pregnancy for both mother and baby.

  • Non-Invasive Prenatal Testing (NIPT)
    Provides expectant parents with critical information about their baby’s genetic health, detecting chromosomal abnormalities like Trisomy 21, 18, and 13 early in the pregnancy.
  • Chromosomal Microarray Analysis (CMA)
    Offers a detailed examination of chromosomes to identify genetic abnormalities during pregnancy, ensuring informed decision-making.

Newborn Screening

Our comprehensive newborn screening services are designed to identify and address serious health conditions right from birth. Early detection allows for prompt intervention, giving every newborn the best start in life with targeted, effective care.

  • Inborn Errors of Metabolism (IEM)
    Comprehensive screening to detect metabolic disorders early, enabling timely intervention and management to prevent severe health outcomes.
  • Severe Combined Immunodeficiency (SCID)
    Early detection of SCID to facilitate prompt treatment, improving the likelihood of better health outcomes for affected newborns.
  • Spinal Muscular Atrophy (SMA)
    Screening for SMA allows for early diagnosis and intervention, crucial for managing this serious genetic disorder.
  • Galactosemia
    Newborn screening for galactosemia helps prevent complications through early dietary management, ensuring the health and safety of the infant.
  • Congenital Adrenal Hyperplasia (CAH)
    Early detection of CAH helps manage and treat adrenal gland disorders effectively, preventing severe complications.
  • Biotinidase Deficiency
    Screening for biotinidase deficiency is vital to prevent metabolic crises and neurological damage, ensuring the well-being of the child.
  • Sickle Cell Disease and Non-Sickle Cell Hemoglobinopathies Including Thalassemia
    Comprehensive screening identifies hemoglobinopathies early, ensuring appropriate care and management to prevent severe health complications.
  • Congenital Hypothyroidism
    Early screening for congenital hypothyroidism is critical to prevent intellectual disability and growth failure through timely thyroid hormone replacement.
  • Cystic Fibrosis
    Screening for cystic fibrosis enables early treatment, significantly improving the quality of life for affected children.
  • G6PD Deficiency
    Detects G6PD deficiency, allowing for appropriate management to avoid hemolytic anemia and other related health issues.

Want to know more about our BabySafe tests?

To learn more about our innovative solutions and how we deliver precise, reliable results, please reach out to us

Unit 201-205, Block D, 17, Kelana Square,
Jalan SS 7/26, SS7, 47301
Petaling Jaya, Selangor,
Malaysia

Call us E-mail

Our Brands

Deparments

  • Molecular Genetics
  • Molecular Diagnostics
  • Biochemical Genetics
  • Health Informatics